Plasma ouabain-like factor during acute and chronic changes in sodium balance in essential hypertension.

作者: Paolo Manunta , Elisabetta Messaggio , Cinzia Ballabeni , Maria Teresa Sciarrone , Chiara Lanzani

DOI: 10.1161/01.HYP.38.2.198

关键词: Blood pressureOuabainEndocrinologyEssential hypertensionLow sodiumDigoxinHomeostasisInternal medicineMedicineSodiumCrossover study

摘要: An ouabain-like factor has been implicated repeatedly in salt-sensitive hypertension as a natriuretic agent. However, the response of plasma to acute and chronic variation body sodium is unclear. We studied 138 patients with essential who underwent an volume expansion/contraction maneuver (2 days) 20 entered blind randomized crossover design involving chronically controlled intake depletion (170 70 mmol/d; 2 weeks each period). In both studies, levels were higher during (acute: 338.8+/-17.4 402.7+/-22.8 pmol/L for baseline low sodium, respectively, P<0.01; chronic: 320.4+/-32.0 versus 481.0+/-48.1 pmol/L, P=0.01). No significant change was observed after 2-hour saline infusion (333.4+/-23.9 pmol/L) or (402.1+/-34.9 pmol/L). When divided into salt-resistant groups, no differences groups at protocols: salt resistant (n=69, 340.1+/-25.9 sensitive 337.4+/-23.6 (n=11, 336.0+/-53.2) (n=9, 301.1+/-331.4 circulating increased by groups. These results demonstrate that raised specifically maneuvers promote loss sodium. Acute expansion fluids isotonic not stimulus factor. Moreover, basal do differ among hypertension. Taken together, these new suggest involved adaptation humans argue against hypothesis hormone.

参考文章(27)
Motilal B. Pamnani, James F. Burris, John F. Jemionek, Stephen J. Huot, Michael Price, Edward D. Freis, Francis J. Haddy, Humoral Na+-K+ pump inhibitory activity in essential hypertension and in normotensive subjects after acute volume expansion. American Journal of Hypertension. ,vol. 2, pp. 524- 531 ,(1989) , 10.1093/AJH/2.7.524
B. R. Boulanger, M. P. Lilly, J. M. Hamlyn, J. Laredo, D. Shurtleff, D. S. Gann, Ouabain is secreted by the adrenal gland in awake dogs American Journal of Physiology-endocrinology and Metabolism. ,vol. 264, ,(1993) , 10.1152/AJPENDO.1993.264.3.E413
Michael N. Margolies, Richard Selden, Thomas W. Smith, RENAL AND GASTROINTESTINAL EXCRETION OF OUABAIN IN DOG AND MAN Journal of Pharmacology and Experimental Therapeutics. ,vol. 188, pp. 615- 623 ,(1974)
S S Gottlieb, A C Rogowski, M Weinberg, C M Krichten, B P Hamilton, J M Hamlyn, Elevated concentrations of endogenous ouabain in patients with congestive heart failure. Circulation. ,vol. 86, pp. 420- 425 ,(1992) , 10.1161/01.CIR.86.2.420
J. M. Hamlyn, M. P. Blaustein, S. Bova, D. W. DuCharme, D. W. Harris, F. Mandel, W. R. Mathews, J. H. Ludens, Identification and characterization of a ouabain-like compound from human plasma Proceedings of the National Academy of Sciences of the United States of America. ,vol. 88, pp. 6259- 6263 ,(1991) , 10.1073/PNAS.88.14.6259
R. P. Garay, M. Alvarez-guerra, J. O. Alda, C. Nazaret, A. Soler, F. Vargas, Regulation of renal Na-K-Cl cotransporter NKCC2 by humoral natriuretic factors: relevance in hypertension. Clinical and Experimental Hypertension. ,vol. 20, pp. 675- 682 ,(1998) , 10.3109/10641969809053245
STEVEN W. GRAVES, An Endogenous Digoxin-Like Substance in Patients with Renal Impairment Annals of Internal Medicine. ,vol. 99, pp. 604- 608 ,(1983) , 10.7326/0003-4819-99-5-604
A. Kawamura, J. Guo, Y. Itagaki, C. Bell, Y. Wang, G. T. Haupert, S. Magil, R. T. Gallagher, N. Berova, K. Nakanishi, On the structure of endogenous ouabain Proceedings of the National Academy of Sciences of the United States of America. ,vol. 96, pp. 6654- 6659 ,(1999) , 10.1073/PNAS.96.12.6654
Paolo Manunta, Amy C. Rogowski, Bruce P. Hamilton, John M. Hamlyn, Ouabain-induced hypertension in the rat: Relationships among plasma and tissue ouabain and blood pressure Journal of Hypertension. ,vol. 12, pp. 549- 560 ,(1994) , 10.1097/00004872-199405000-00008